Remote diet coaching tested for pancreatic cancer patients
NCT ID NCT06050395
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested whether a remote nutrition coaching program is practical and well-liked by people with pancreatic cancer who are undergoing chemotherapy. Forty participants were asked to complete online food questionnaires and attend coaching sessions over 12 weeks. The goal was to see if patients would stick with the program and find it helpful, not to measure direct health effects.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- remote nutrition coaching and monitoring
- What this could lead to
- If successful, this approach could help improve quality of life and treatment response for pancreatic cancer patients undergoing chemotherapy.
- What could go wrong
- This is a small, early feasibility study with only 40 participants. It does not directly test whether the intervention improves health outcomes, only if it is practical and acceptable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?
- Can a pill rouse the immune system against pancreatic cancer?